Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4425474 | 0.86 | LPL (0.47) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL30622816 | 0.86 | LPL (0.47) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL57994 | 0.85 | LPL (0.46) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL16688104 | 0.85 | LPL (0.46) | LPLLIPGCA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL28537357 | 0.85 | LPL (0.46) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL4426022 | 0.85 | LPL (0.46) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL24524492 | 0.83 | LPL (0.44) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL177624 | 0.83 | LPL (0.44) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL1437613 | 0.83 | EGFR (0.55) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL31342073 | 0.83 | LPL (0.51) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090589-A1 | HETEROCYCLIC HBS1L DEGRADERS | TANGO THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20230331654-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230331654-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-10647733-B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | THE UNIVERSITY OF CHICAGO (US) | 2020-05-12 | — | — | US | disclosed |
| US-20170182486-A1 | METAL-ORGANIC FRAMEWORKS CONTAINING NITROGEN-DONOR LIGANDS FOR EFFICIENT CATALYTIC ORGANIC TRANSFORMATIONS | THE UNIVERSITY OF CHICAGO (US) | 2017-06-29 | — | — | US | disclosed |
| US-20150191493-A1 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | Universite de Bordeaux (FR) | 2015-07-09 | — | — | US | disclosed |
| US-20150191493-A1 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | Universite de Bordeaux (FR) | 2015-07-09 | — | — | US | disclosed |
| US-20150191493-A1 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | Universite de Bordeaux (FR) | 2015-07-09 | — | — | US | disclosed |
| EP-2684887-B1 | New process for preparing arylboranes by arylation of organoboron compounds | UNIV BORDEAUX (FR) | 2015-06-17 | — | — | EP | disclosed |
| EP-2872519-A1 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | UNIVERSITE DE BORDEAUX (FR) | 2015-05-20 | — | — | EP | disclosed |
| US-8404670-B2 | Histamine H3 inverse agonists and antagonists and methods of use thereof | SUNOVION PHARMACEUTICALS INC. (US) | 2013-03-26 | — | — | US | disclosed |
| EP-2481742-A1 | PREPARATION METHOD OF AROMATIC BORATE ESTER COMPOUND | Peking University (CN) | 2012-08-01 | — | — | EP | disclosed |
| EP-2481742-A1 | PREPARATION METHOD OF AROMATIC BORATE ESTER COMPOUND | Peking University (CN) | 2012-08-01 | — | — | EP | disclosed |
| US-20120184768-A1 | PREPARATION METHOD OF AROMATIC BORONATE COMPOUNDS | PEKING UNIVERSITY (CN) | 2012-07-19 | — | — | US | disclosed |
| US-20120184768-A1 | PREPARATION METHOD OF AROMATIC BORONATE COMPOUNDS | PEKING UNIVERSITY (CN) | 2012-07-19 | — | — | US | disclosed |
| US-20120022050-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. | 2012-01-26 | — | — | US | disclosed |
| EP-2396327-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | Sunovion Pharmaceuticals Inc. (US) | 2011-12-21 | — | — | EP | disclosed |
| US-8063032-B2 | Histamine H3 inverse agonists and antagonists and methods of use thereof | SUNOVION PHARMACEUTICALS INC. (US) | 2011-11-22 | — | — | US | disclosed |
| WO-2010093425-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SEPRACOR INC. (US) | 2010-08-19 | — | — | WO | disclosed |
| US-20100204214-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331654-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | OCIAD1, OCIAD2, ORAI2 | LPL 601/4885LIPG 380/4885CA1 3213/4885 |
| US-10647733-B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | NCLN, MDH1, NNMT | LPL 4013/4885LIPG 3849/4885CA1 1109/4885 |
| US-20170182486-A1 | METAL-ORGANIC FRAMEWORKS CONTAINING NITROGEN-DONOR LIGANDS FOR EFFICIENT CATALYTIC ORGANIC TRANSFORMATIONS | NCLN, MDH1, NNMT | LPL 4013/4885LIPG 3849/4885CA1 1109/4885 |
| US-20120184768-A1 | PREPARATION METHOD OF AROMATIC BORONATE COMPOUNDS | AHR, BLVRB, AR | LPL 4008/4885LIPG 3859/4885CA1 4497/4885 |
| US-20100204214-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | HRH3, HRH4, HRH2 | LPL 3488/4885LIPG 3575/4885CA1 1722/4885 |
| US-20120022050-A1 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | HRH3, HRH4, HRH2 | LPL 3488/4885LIPG 3575/4885CA1 1722/4885 |
| US-20150191493-A1 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | NISCH, BRD7, BRSK2 | LPL 4543/4885LIPG 4066/4885CA1 4257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.